A study of 4,080 animals was conducted to compare the efficacy of a single dose of EXCEDE® (1.5 mL/100 lbs.) to a single dose of Micotil® (tilmicosin, 1.5 mL/100 lb.) for metaphylactic BRD control.1
At Day 15, morbidity was considerably lower (P < 0.05) for cattle treated with EXCEDE with a seven-day post-metaphylaxis interval (PMI)* than for cattle treated with Micotil with a three-day PMI or negative control cattle.1
*The PMI is the period of time after metaphylaxis when no additional BRD treatments are administered.
In a three-site study of 1,760 cattle, a single dose of EXCEDE followed by a seven-day post-treatment interval (PTI)* significantly increased 56-day treatment success compared with a three-day PTI using a single dose of EXCEDE or Baytril.2
*The PTI is a period of time after antimicrobial treatment when no further treatments for BRD are administered.
Fewer treatment failures than Baytril2
Cattle treated with EXCEDE followed by a seven-day PTI resulted in fewer treatment failures than did EXCEDE with a three-day PTI or Baytril followed by a three-day PTI.2
IMPORTANT SAFETY INFORMATION FOR CATTLE: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Inadvertent intra-arterial injection is possible and fatal. Do not use in calves to be processed for veal. Pre-slaughter withdrawal time is 13 days following the last dose. See full Prescribing Information.
1 Data on file, Study Report No. SR-0829-7922-2003-007, Zoetis.
2 Data on file, Study Report No. SR-0829-7922-2003-005, Zoetis.
Baytril is a registered trademark of Bayer. Micotil is a registered trademark of Eli Lilly and Company. Nuflor and Zuprevo are trademarks of Merck Animal Health. Zactran is a registered trademark of Merial.